published report , page-23

Hi Biotech,

You wrote;

Also Muz... I'm reading through the most recent COC/COP publication and this is the 3rd/4th+ time I've seen the mention of work with TnI, Thyroid-stimulating hormone and TNF_alpha... Surely they aren't researching work with these 3 proteins over and over again by coincidence? We know TnI is for POC1, but what are the other two biomarkers being researched for? Or who for? POC1? Alere? Other?

In the October 23, 2013 Australian Microcap Investment Conference Presentation, slide 11 titled 'The Proof Is In The Data' showed that TNF-a showed a sensitivity improvement of 50 fold! 50 fold!! I had to do a double take when I first saw this figure in the announcement. Do you have any thoughts on what this improvement may actually mean for Anteo and/or prospective partners going forward?

http://www.anteodx.com/icms_docs/170099_MIxGoTM_-_A_Universal_Glue__For_Clinical_Diagnostics_Life_Sciences_and_beyond.pdf

Regards,
Tony